
News



Lisa Henderson discusses the debate around aligning of sponsor and CRO in a more integrated way to run clinical trials from a project or portfolio standpoint and gain efficiencies and ultimately save money.








Medidata Minute Episode 2: Recorded live at the Forbes Health Care Summit, Harlan Krumholz, Professor of Medicine Epidemiology & Public Health, Yale University and Andy Slavitt, group executive vice president at Optum discuss regulation in healthcare


Multimedia: Editorial Director Lisa Henderson talks with Steve Powell, PRA Executive VP Clinical Informatics and Late Phase Services about PRA's Informatics Expansion at its new Swansea, Wales office

Video Blog-- Strategic Outsourcing: A Concept for Debate? Are strategic partnerships in a too-early-to-tell stage? A passing fad or here to stay



Applied Clinical Trials Editorial talks with CluePoints' Founder Marc Buyse about the history of CluePoints as well as the role of biostatistics in clinical trials









Industry news focusing on the people and organizations who work in the clinical trials profession.

Risk-based monitoring was in Trans-Celerate BioPharma's sights since the pharmaceutical company collaborative was announced in September 2012.

Food and Drug Administration officials are busy implementing its provisions that offer new approaches to clinical trial design and application review.

Treatment networks and network meta-analysis of randomized trials can boost understanding of how much evidence is available for each treatment and treatment comparison.

Industry Standard Research

.png)



.png)



.png)
.png)
